Anke Verlinden
Impact in
- Oncology top 10%
- Neutropenia and Cancer Infections
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Papers in
- Immunology 11
- Mast cells and histamine 6
- Immunotherapy and Immune Responses 3
-
- Hematopoietic Stem Cell Transplantation 3
- Co-authors
- Alain Gadisseur (9 shared papers)Wilfried Schroyens (8 shared papers)Zwi Nisan Berneman (9 shared papers)Herman Goossens (4 shared papers)Hilde Jansens (2 shared papers)Diana Averbuch (1 shared paper)Małgorzata Mikulska (1 shared paper)Jan Styczyński (1 shared paper)
- Journals
- Blood (4 papers)Bone Marrow Transplantation (2 papers)European Journal Of Haematology (2 papers)Journal of Immunological Methods (1 paper)Journal of Clinical Apheresis (1 paper)
- Partner nations
- BelgiumNetherlandsAustria
In The Last Decade
Anke Verlinden
26 papers receiving 517 citations
Peers
Comparison fields: 5 of 48
- Oncology 259
- Hematology 99
- Immunology 181
- Applied Microbiology and Biotechnology 9
- Clinical Biochemistry 28
Countries citing papers authored by Anke Verlinden
This map shows the geographic impact of Anke Verlinden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Verlinden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Verlinden more than expected).
Fields of papers citing papers by Anke Verlinden
This network shows the impact of papers produced by Anke Verlinden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Verlinden. The network helps show where Anke Verlinden may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke Verlinden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 195 | |
| 2 | 2020 | 49 | |
| 3 | 2021 | 36 | |
| 4 | 2023 | 33 | |
| 5 | 2014 | 31 | |
| 6 | 2013 | 20 | |
| 7 | 2020 | 16 | |
| 8 | 2017 | 15 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 12 | |
| 11 | 2019 | 11 | |
| 12 | 2022 | 11 | |
| 13 | 2021 | 9 | |
| 14 | 2016 | 9 | |
| 15 | 2017 | 9 | |
| 16 | 2016 | 9 | |
| 17 | 2021 | 8 | |
| 18 | 2014 | 8 | |
| 19 | 2016 | 5 | |
| 20 | 2017 | 5 |
About Anke Verlinden
Anke Verlinden is a scholar working on Immunology, Hematology, Oncology, Clinical Biochemistry and Public Health, Environmental and Occupational Health, having authored 29 papers that have together received 522 indexed citations. Recurring topics across this work include Mast cells and histamine (6 papers), Neutropenia and Cancer Infections (6 papers), Bacterial Identification and Susceptibility Testing (4 papers), Renal and related cancers (4 papers), Acute Lymphoblastic Leukemia research (3 papers), RNA Interference and Gene Delivery (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Oncology (259 citations), Hematology (99 citations), Immunology (181 citations), Applied Microbiology and Biotechnology (9 citations) and Clinical Biochemistry (28 citations). Anke Verlinden has collaborated with scholars based in Belgium, Netherlands and Austria. Frequent co-authors include Alain Gadisseur, Wilfried Schroyens, Zwi Nisan Berneman, Herman Goossens, Hilde Jansens, Diana Averbuch, Małgorzata Mikulska, Jan Styczyński, Nina Simone Knelange and Ann Van de Velde. Their work appears in journals such as Blood, Bone Marrow Transplantation, European Journal Of Haematology, Journal of Immunological Methods and Journal of Clinical Apheresis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.